Bicycle Therapeutics
BCYC
18 hedge funds and large institutions have $144M invested in Bicycle Therapeutics in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
45% more capital invested
Capital invested by funds: $98.9M → $144M (+$44.7M)
13% more funds holding
Funds holding: 16 → 18 (+2)
6.98% more ownership
Funds ownership: 34.76% → 41.74% (+7%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$17M |
| 2 |
SC
Samlyn Capital
New York
|
+$7.39M |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$548K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$28.3K |
| 5 |
Morgan Stanley
New York
|
+$9.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$987K |
| 2 |
AVA
Atlas Venture Advisors
Boston,
Massachusetts
|
-$984K |
| 3 |
Renaissance Technologies
New York
|
-$269K |
| 4 |
Squarepoint
New York
|
-$163K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$141K |
BCYC Hedge Fund Activity: Q3 2020 in Review
18 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q3 2020, worth a combined $144M — up 45% from $98.9M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BCYC positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 7 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $17M. The largest seller was Victory Capital Management, cutting an estimated $987K.
- 18 institutional investors held Bicycle Therapeutics (BCYC) as of Q3 2020, up from 16 in Q2 2020.
- Funds reported $144M of Bicycle Therapeutics stock for Q3 2020, up 45% quarter-over-quarter.
- 4 funds opened new Bicycle Therapeutics positions in Q3 2020 and 2 closed out, a net change of +2 holders.
- The largest Bicycle Therapeutics buyer in Q3 2020 was Point72 Asset Management, an estimated $17M added.
- The largest Bicycle Therapeutics seller in Q3 2020 was Victory Capital Management, an estimated $987K sold.
Based on aggregated 13F filings for Q3 2020.